Clinical trial
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell…
NCT00101608 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00101608 |
|---|---|
| Title | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium |
| Official title | A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Pierre Fabre Medicament Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Transitional Cell Carcinoma, Bladder Neoplasms, Kidney Neoplasms, Ureter Neoplasms, Bladder Cancer, Neoplasm, Bladder |
| Intervention type | Drug |
| Interventions | vinflunine |
| Enrollment | 150 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jan 13, 2005 |
| Last update posted | Mar 2, 2010 |
| Countries | Australia, Austria, Canada, France, Greece, Indonesia, Italy, Philippines, Singapore, South Korea, Spain, Sweden and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: